TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...
Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment ...
Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Founded in 1678 ...
Bain Capital has promoted Ivano Sessa to be co-head of European private equity as the investment firm is shaking up its leadership ranks in the region. The 47-year-old Italian will help lead the ...
“Milacron is an iconic American manufacturing business with a 50-year legacy of driving innovation in plastics,” said Matt Evans, a partner at Bain Capital Special Situations in a statement.
Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...
Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It is a new position. Largay oversees the team’s debt and financing ...
Insignia's shares peak to a 3-year high Due diligence to Bain, CC Capital granted Bain matches CC Capitals' A$4.43 apiece offer Jan 23 (Reuters) - Insignia Financial's (IFL.AX), opens new tab ...
Bengaluru: US private equity firm Bain Capital had invested an undisclosed amount in Dhoot Transmission Group, an Aurangabad-based automotive component manufacturer. Bain Capital did not disclose ...
Gift 5 articles to anyone you choose each month when you subscribe. It’s mano-a-mano at Insignia Financial, the ASX-listed wealth giant put into play by Bain Capital in December. Street Talk ...
US-based Bain Capital has increased its takeover bid for Australian wealth manager Insignia Financial to A$2.87bn ($1.76bn). The offer matches the indicative non-binding buyout offer made last ...